This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: The University of Edinburgh. Active years: 2014-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2019
Title: Asier Unciti-Broceta: Innovator in Pharmaceutical Compounds
Introduction
Asier Unciti-Broceta is a prominent inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and cationic lipids. With a total of 2 patents, his work is recognized for its potential therapeutic applications.
Latest Patents
Unciti-Broceta's latest patents include innovative compounds that relate to a specific formula designed for pharmaceutical use. The first aspect of his invention involves a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof. This compound features various substituents that enhance its therapeutic potential. Additionally, he has developed cationic lipids that are crucial for drug delivery systems, showcasing his expertise in pharmaceutical compositions and their therapeutic uses.
Career Highlights
Asier Unciti-Broceta is affiliated with the University of Edinburgh, where he conducts research and develops his inventions. His academic background and research focus have positioned him as a key figure in the pharmaceutical innovation landscape. His work not only contributes to scientific knowledge but also has practical implications for drug development.
Collaborations
Throughout his career, Unciti-Broceta has collaborated with notable colleagues, including Aleksandra Liberska and Neil O Carragher. These collaborations have further enriched his research and expanded the impact of his inventions in the pharmaceutical field.
Conclusion
Asier Unciti-Broceta is a distinguished inventor whose work in pharmaceutical compounds and cationic lipids has the potential to advance therapeutic applications. His contributions reflect a commitment to innovation and excellence in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
